Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jefferies Financial Group
JEF
|
+$460M |
| 2 |
Palo Alto Networks
PANW
|
+$363M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$330M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$291M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caterpillar
CAT
|
+$755M |
| 2 |
Microsoft
MSFT
|
+$674M |
| 3 |
Apple
AAPL
|
+$642M |
| 4 |
Flutter Entertainment
FLUT
|
+$572M |
| 5 |
NVIDIA
NVDA
|
+$512M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.64% |
| 2 | Consumer Discretionary | 7.06% |
| 3 | Financials | 6.47% |
| 4 | Healthcare | 4.72% |
| 5 | Communication Services | 4.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GOCO
4951
DELISTED
GoHealth
GOCO
| $47.7K | ﹤0.01% |
3,564
+275
| +8% | +$3.13K |
|
4952
Ramaco Resources Class B
METCB
$443M
| $47.7K | ﹤0.01% |
5,084
+11
| +0.2% | +$107 |
|
|
CVAC
4953
DELISTED
CureVac
CVAC
| $47.7K | ﹤0.01% |
13,976
+5,677
| +68% | +$16.4K |
|
|
IGA
4954
Voya Global Advantage and Premium Opportunity Fund
IGA
$156M
| $47K | ﹤0.01% |
5,113
+2,113
| +70% | +$20K |
|
4955
PepGen
PEPG
$127M
| $46.9K | ﹤0.01% |
12,385
+923
| +8% | +$5.75K |
|
4956
Gran Tierra Energy
GTE
$226M
| $46.8K | ﹤0.01% |
6,472
+3,029
| +88% | +$19.7K |
|
4957
United States Antimony
UAMY
$772M
| $46.3K | ﹤0.01% |
+26,133
| New | +$26.2K |
|
|
AGEN
4958
Agenus
AGEN
$275M
| $46K | ﹤0.01% |
16,771
+1,480
| +10% | +$5.48K |
|
4959
Forafric Global
AFRI
$282M
| $45.8K | ﹤0.01% |
4,471
+389
| +10% | +$4.04K |
|
4960
Establishment Labs
ESTA
$2.7B
| $45.7K | ﹤0.01% |
992
+914
| +1,172% | +$39.8K |
|
4961
Cosan
CSAN
$3.07B
| $45.5K | ﹤0.01% |
8,371
+2,198
| +36% | +$16.5K |
|
|
BNT
4962
Brookfield Wealth Solutions
BNT
$11.8B
| $45.4K | ﹤0.01% |
1,185
+1,180
| +23,600% | +$44.5K |
|
4963
Ovid Therapeutics
OVID
$440M
| $45.3K | ﹤0.01% |
48,551
+4,599
| +10% | +$5.15K |
|
4964
Global X Silver Miners ETF NEW
SIL
$3.99B
| $45K | ﹤0.01% |
1,415
-55,686
| -98% | -$2.04M |
|
4965
First Trust Exchange-Traded Fund II First Trust International Equity Opportunities ETF
FPXI
$265M
| $44.8K | ﹤0.01% |
950
+200
| +27% | +$9.78K |
|
|
BXMX
4966
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
| $44.6K | ﹤0.01% |
3,186
| – | – |
|
4967
ProShares UltraPro S&P 500
UPRO
$5.12B
| $44.3K | ﹤0.01% |
500
| – | – |
|
4968
Valhi
VHI
$386M
| $44.3K | ﹤0.01% |
1,892
+98
| +5% | +$2.91K |
|
4969
Critical Metals Corp
CRML
$831M
| $44.2K | ﹤0.01% |
6,505
+1,232
| +23% | +$8.24K |
|
|
GBIO
4970
DELISTED
Generation Bio
GBIO
| $44K | ﹤0.01% |
4,148
+436
| +12% | +$7.77K |
|
|
CLPR
4971
Clipper Realty
CLPR
$46.5M
| $43.9K | ﹤0.01% |
9,588
+1,003
| +12% | +$5.64K |
|
4972
FibroBiologics
FBLG
$3.95M
| $43.8K | ﹤0.01% |
1,095
+93
| +9% | +$4.99K |
|
4973
SLR Investment Corp
SLRC
$708M
| $43.7K | ﹤0.01% |
2,705
+592
| +28% | +$9.41K |
|
4974
Amprius Technologies
AMPX
$1.29B
| $43.4K | ﹤0.01% |
15,508
+3,565
| +30% | +$6.23K |
|
4975
Skye Bioscience
SKYE
$21.6M
| $43.2K | ﹤0.01% |
15,262
+2,738
| +22% | +$11.4K |
|
Similar funds
Citigroup's Q4 2024 Portfolio in Review
As of Q4 2024, Citigroup held 6,077 positions worth $169B, down 2.4% from $173B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Citigroup withdrew a net $7.85B in Q4 2024, closing 263 positions and reducing 1,533 holdings. Its most notable exit was Stericycle Inc, an estimated $125M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Citigroup opened a new position in T-Rex 2X Long MSTR Daily Target ETF worth $19M.
- Citigroup's largest Q4 2024 buy was T-Rex 2X Long MSTR Daily Target ETF: 249,467 shares worth $19M.
- Citigroup added most to Jefferies Financial Group in Q4 2024, an estimated $460M increase.
- Citigroup's biggest Q4 2024 reduction was Caterpillar, cutting an estimated $755M.
- Citigroup fully exited Stericycle Inc in Q4 2024, selling an estimated $125M.
- Citigroup's ten largest holdings make up 21% of its $169B portfolio in Q4 2024.
- Citigroup opened 429 new positions and closed 263 in Q4 2024.
- Citigroup's portfolio value fell 2.4% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q4 2024, filed 12 Feb 2025.